Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer.

Planque C, de Monte M, Guyetant S, Rollin J, Desmazes C, Panel V, Lemarié E, Courty Y.

Biochem Biophys Res Commun. 2005 Apr 22;329(4):1260-6.

PMID:
15766562
2.

Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.

Dong Y, Kaushal A, Brattsand M, Nicklin J, Clements JA.

Clin Cancer Res. 2003 May;9(5):1710-20.

3.

Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies.

Li X, Liu J, Wang Y, Zhang L, Ning L, Feng Y.

Cancer Sci. 2009 Apr;100(4):601-7. doi: 10.1111/j.1349-7006.2009.01090.x.

4.

Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.

Planque C, Aïnciburu M, Heuzé-Vourc'h N, Régina S, de Monte M, Courty Y.

Biol Chem. 2006 Jun;387(6):783-8.

PMID:
16800740
5.

A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.

Planque C, Li L, Zheng Y, Soosaipillai A, Reckamp K, Chia D, Diamandis EP, Goodglick L.

Clin Cancer Res. 2008 Mar 1;14(5):1355-62. doi: 10.1158/1078-0432.CCR-07-4117.

6.

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.

Kim H, Scorilas A, Katsaros D, Yousef GM, Massobrio M, Fracchioli S, Piccinno R, Gordini G, Diamandis EP.

Br J Cancer. 2001 Mar 2;84(5):643-50.

7.

Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.

Talieri M, Mathioudaki K, Prezas P, Alexopoulou DK, Diamandis EP, Xynopoulos D, Ardavanis A, Arnogiannaki N, Scorilas A.

Thromb Haemost. 2009 Apr;101(4):741-7.

PMID:
19350120
8.

Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues.

Yousef GM, Scorilas A, Chang A, Rendl L, Diamandis M, Jung K, Diamandis EP.

Prostate. 2002 May 1;51(2):126-32.

PMID:
11948967
9.

Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.

Kyriakopoulou LG, Yousef GM, Scorilas A, Katsaros D, Massobrio M, Fracchioli S, Diamandis EP.

Clin Biochem. 2003 Mar;36(2):135-43.

PMID:
12633763
10.

Differential expression of Kallikrein gene 5 in cancerous and normal testicular tissues.

Yousef GM, Obiezu CV, Jung K, Stephan C, Scorilas A, Diamandis EP.

Urology. 2002 Oct;60(4):714-8.

PMID:
12385949
11.

Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer.

Yousef GM, Scorilas A, Kyriakopoulou LG, Rendl L, Diamandis M, Ponzone R, Biglia N, Giai M, Roagna R, Sismondi P, Diamandis EP.

Clin Chem. 2002 Aug;48(8):1241-50.

12.

Alternative splicing variant of kallikrein-related peptidase 8 as an independent predictor of unfavorable prognosis in lung cancer.

Planque C, Choi YH, Guyetant S, Heuzé-Vourc'h N, Briollais L, Courty Y.

Clin Chem. 2010 Jun;56(6):987-97. doi: 10.1373/clinchem.2009.138917. Epub 2010 Apr 1.

13.

Quantitative analysis of human kallikrein 5 (KLK5) expression in prostate needle biopsies: an independent cancer biomarker.

Korbakis D, Gregorakis AK, Scorilas A.

Clin Chem. 2009 May;55(5):904-13. doi: 10.1373/clinchem.2008.103788. Epub 2009 Mar 19.

14.

Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function.

Dong Y, Matigian N, Harvey TJ, Samaratunga H, Hooper JD, Clements JA.

Biol Chem. 2008 Feb;389(2):99-109. doi: 10.1515/BC.2008.013.

PMID:
18163887
15.

Disordered expression of HOX genes in human non-small cell lung cancer.

Abe M, Hamada J, Takahashi O, Takahashi Y, Tada M, Miyamoto M, Morikawa T, Kondo S, Moriuchi T.

Oncol Rep. 2006 Apr;15(4):797-802.

PMID:
16525661
16.

Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.

Li R, An SJ, Chen ZH, Zhang GC, Zhu JQ, Nie Q, Xie Z, Guo AL, Mok TS, Wu YL.

Hum Pathol. 2008 Dec;39(12):1792-801. doi: 10.1016/j.humpath.2008.05.008. Epub 2008 Aug 19.

PMID:
18715616
17.

Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin.

Johnson SK, Ramani VC, Hennings L, Haun RS.

Cancer. 2007 May 1;109(9):1811-20.

18.

Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer.

Holzscheiter L, Biermann JC, Kotzsch M, Prezas P, Farthmann J, Baretton G, Luther T, Tjan-Heijnen VC, Talieri M, Schmitt M, Sweep FC, Span PN, Magdolen V.

Clin Chem. 2006 Jun;52(6):1070-9. Epub 2006 Apr 20.

19.

Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung.

Planque C, Bléchet C, Ayadi-Kaddour A, Heuzé-Vourc'h N, Dumont P, Guyétant S, Diamandis EP, El Mezni F, Courty Y.

Biol Chem. 2008 Jun;389(6):781-6. doi: 10.1515/BC.2008.089.

PMID:
18627302
20.

Down-regulation of Gadd45 expression is associated with tumor differentiation in non-small cell lung cancer.

Higashi H, Vallböhmer D, Warnecke-Eberz U, Hokita S, Xi H, Brabender J, Metzger R, Baldus SE, Natsugoe S, Aikou T, Hölscher AH, Schneider PM.

Anticancer Res. 2006 May-Jun;26(3A):2143-7.

Supplemental Content

Support Center